摘要
目的:讨论一例重症胰腺炎伴发多药耐药(MDR)肺炎克雷伯菌(Kpn)脓毒血症治疗成功的抗感染策略,为MDR-Kpn的治疗积累经验。方法:记录病人的临床表现,结合各项实验室检验指标及抗感染治疗药物种类、疗程及联用方案,分析抗菌药物治疗策略。结果:该例病人住院期间依次使用了替加环素+亚胺培南/西司他汀钠、替加环素+亚胺培南/西司他汀钠+阿米卡星、替加环素+头孢哌酮钠/舒巴坦钠、头孢哌酮钠/舒巴坦钠+阿米卡星、头孢哌酮钠/舒巴坦钠+磷霉素的多药联合治疗方案。入院第52天血培养转阴并保持,各项细菌感染炎性指标转为正常,病情好转稳定,MDR-Kpn脓毒血症治愈。结论:MDR-Kpn在缺乏明确有效的抗菌药物时,及时联合应用治疗Kpn的一线和二线药物,延长疗程是治疗成功的关键。
Objective: To discuss the anti-infection strategy for the successful treatment of a case of severe pancreatitis combined with multiple drug resistant Klebsiella pneumoniae (MDR-Kpn) sepsis and to accumulate clinical experience for the treatment of MDR-Kpn. Methods:Anti-bacterial drug treatment strategy was analyzed through recording of clinical manifesta- tions associated with various biochemical indicators and categories of anti-infectious drugs, treatment courses and drug combina- tion profiles. Results:During hospitalization, the patient was treated in sequence with various combinations of antibiotics, inclu- ding tigecycline plus imipenem/eilastatin sodium, tigeeyeline plus imipenem/cilastatin sodium plus amikacin, tigecycline plus eef operazone sodium/sulbaetam sodium, cefoperazone sodium/sulbactam sodium plus amikaein,and eefoperazone sodium/sulbactam sodium plus fosfomycin. Fifty-two days after admission into the hospital, blood culture turned negative and was stably main- tained. All the inflammatory markers returned to normal. The patient's conditions became stable, and finally this rare case of MDR-Kpn sepsis was cured successfully. Conclusion: Without definitively effective anti-bacterials, in-time combined therapy with first-line and second-line drugs and with extended treatment courses was the key to the successful treatment of MDR-Kpn sepsis.
出处
《药学服务与研究》
CAS
2015年第5期329-333,共5页
Pharmaceutical Care and Research
关键词
肺炎克雷伯菌
多药耐药
联合用药
重症胰腺炎
脓毒血症
Klebsiella pneumonia
multiple drug resistance
combined medication
severe pancreatitis
sepsis